Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial49

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial28

Views

Views
December 20241
January 20254
February 20253
March 202516
April 20254
May 20250
June 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States11
Brazil1
Spain1
United Kingdom1
 

Top cities views

Views
Cerquilho1
Council Bluffs1
Elk Grove Village1